Review
Published on 15 Mar 2021
Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2021.638400
- 12,014 views
- 23 citations
